IP Library › Granted Patent US 11,653,840
Granted Patent B2
US 11,653,840 · App. 16/675,394 · Granted May 23, 2023

System and method for providing blood pressure safe zone indication during autoregulation monitoring

Inventors: Paul Stanley Addison (Edinburgh, GB); James N. Watson (Edinburgh, GB); Dean Montgomery (Edinburgh, GB)
Assignee: COVIDIEN LP
A61B5/0205A61B5/021A61B5/026A61B5/02028A61B5/14546A61B5/14553A61B5/4064A61B5/7246A61B5/742A61B5/743A61B5/7425G16H40/63G16H50/20G16H50/30A61B5/0059A61B5/0261A61B5/031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,653,840
App. No.
16/675,394
Granted
May 23, 2023
Kind
B2
Abstract

A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.

Claims (61)

1. A monitor for monitoring autoregulation, the monitor comprising:

a display;

a memory encoding one or more processor-executable instructions; and

one or more processors configured to access and execute the one or more instructions encoded by the memory, wherein the instructions, when executed, cause the one or more processors to: receive one or more physiological signals from a patient;

determine a correlation-based measure indicative of an autoregulation of the patient based on the one or more physiological signals;

generate an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure, wherein the autoregulation profile comprises the autoregulation index values sorted into bins corresponding to different blood pressure ranges;

designate a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact autoregulation;

provide a first signal to the display to display the autoregulation profile and a first indicator of the blood pressure safe zone; and

provide a second signal to the display or other output device to provide an audible or visual indication that a current blood pressure of the patient is outside the blood pressure safe zone.

2. The monitor of claim 1 , wherein the correlation-based measure is one of a cerebral oximetry index, a hemoglobin volume index, or a mean velocity index.

3. The monitor of claim 1 , wherein the one or more instructions, when executed, cause the one or more processors to:

receive patient specific inputs, the patient specific inputs being physical characteristics of the patient,

wherein the instructions to designate the blood pressure range encompassing one or more of the bins as the blood pressure safe zone indicative of intact autoregulation comprise instructions to designate the blood pressure range encompassing one or more of the bins as an initial blood pressure safe zone indicative of intact autoregulation utilizing at least historical population data based on the patient specific inputs, and

wherein the instructions to provide the first signal to the display comprise instructions to provide a signal to display an indicator of the initial blood pressure safe zone.

4. The monitor of claim 3 , wherein the instructions to designate the blood pressure range encompassing one or more of the bins as the initial blood pressure safe zone indicative of intact autoregulation comprise instructions to designate the blood pressure range as the initial blood pressure safe zone utilizing both the historical population data based on the patient specific inputs and initially measured baselines of physiological parameters of the patient.

5. The monitor of claim 3 , wherein the one or more instructions, when executed, cause the one or more processors to:

determine if there is sufficient data within the autoregulation profile to designate a patient-specific blood pressure safe zone;

in response to determining that there is sufficient data, designate the blood pressure range encompassing one or more of the bins as a patient-specific blood pressure safe zone indicative of intact autoregulation; and

provide a third signal to the display to display an indicator of the patient-specific blood pressure safe zone,

wherein the indicator of the initial blood pressure safe zone comprises a first color, and

wherein the indicator of the patient-specific blood pressure safe zone comprises a second color different from the first color.

6. The monitor of claim 5 ,

wherein the indicator of the initial blood pressure safe zone comprises a first type of marking, and

wherein the indicator of the patient-specific blood pressure safe zone comprises a second type of marking different from the first type of marking.

7. The monitor of claim 6 ,

wherein the first type of marking comprises hatching, and

wherein the second type of marking comprises no hatching.

8. The monitor of claim 1 ,

wherein the audible or visual indication comprises a first audible or visual indication that indicates that the current blood pressure is higher than the blood pressure safe zone and a second audible or visual indication that the current blood pressure is lower than the blood pressure safe zone, and

wherein the first audible or visual indication is different from the second audible or visual indication.

9. The monitor of claim 1 , wherein the instructions to provide the first signal to the display comprise instructions to cause the display to flash the autoregulation profile and the first indicator of the blood pressure safe zone on and off.

10. The monitor of claim 1 , wherein the instructions to provide the first signal to the display comprise instructions to provide the first signal to the display to display a blood pressure history of the patient, wherein the blood pressure history depicts an amount of time blood pressure measurements within the bins are within the blood pressure safe zone.

11. The monitor of claim 10 , wherein the first indicator of the blood pressure safe zone overlays a portion of the autoregulation profile corresponding to the blood pressure safe zone.

12. The monitor of claim 1 , wherein the one or more processors and the display are supported within one housing.

13. The monitor of claim 1 ,

wherein the one or more instructions, when executed, cause the one or more processors to determine that a current blood pressure of the patient is outside the blood pressure safe zone, and

wherein the instructions to provide the second signal comprise instructions to cause the display to flash the autoregulation profile or flash the first indicator of the blood pressure safe zone in response to determining that the current blood pressure of the patient is outside the blood pressure safe zone.

14. The monitor of claim 1 , wherein the instructions to provide the first signal to the display comprise instructions to cause the display to present the blood pressure safe zone including a first color in response to determining that a current blood pressure of the patient is within the blood pressure safe zone, and

wherein the instructions to provide the second signal comprise instructions to cause the display to present the blood pressure safe zone including a second color in response to determining that the current blood pressure of the patient is outside of the blood pressure safe zone, the second color being different than the first color.

15. The monitor of claim 14 ,

wherein the first color comprises green, and

wherein the second color comprises red.

16. The monitor of claim 14 , wherein the instructions to provide the first signal to the display further comprise instructions to cause the display to present the blood pressure safe zone including a third color in response to determining that the current blood pressure of the patient is approaching an outer limit of the blood pressure safe zone, the third color being different than the first and second colors.

17. The monitor of claim 16 ,

wherein the first color comprises green,

wherein the second color comprises red, and

wherein the third color comprises yellow or orange.

18. A method for monitoring autoregulation, the method comprising:

receiving, by one or more processors executing one or more instructions encoded on a memory, one or more physiological signals from a patient;

determining, by the one or more processors, a correlation-based measure indicative of an autoregulation of the patient based on the one or more physiological signals;

generating, by the one or more processors, an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure, wherein the autoregulation profile comprises the autoregulation index values sorted into bins corresponding to different blood pressure ranges;

designating, by the one or more processors, a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact autoregulation;

providing, by the one or more processors and to a display, a first signal to display the autoregulation profile and a first indicator of the blood pressure safe zone; and

providing, by the one or more processors and to the display or other output device, a second signal to provide an audible or visual indication that a current blood pressure of the patient is outside the blood pressure safe zone.

19. A device comprising a computer-readable medium having executable instructions stored thereon, configured to be executable by processing circuitry for causing the processing circuitry to:

receive one or more physiological signals from a patient;

determine a correlation-based measure indicative of an autoregulation of the patient based on the one or more physiological signals;

generate an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure, wherein the autoregulation profile comprises the autoregulation index values sorted into bins corresponding to different blood pressure ranges;

designate a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact autoregulation;

provide a first signal to the display to display the autoregulation profile and a first indicator of the blood pressure safe zone; and

provide a second signal to the display to display a second indicator of a target blood pressure within the blood pressure safe zone for the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: ADDISON, PAUL STANLEY; WATSON, JAMES N.; MONTGOMERY, DEAN
To: COVIDIEN LP
Reel/Frame 051547/0349 →
Continuity (3)
Continuation 15296150 · Oct 18, 2016
Provisional Application 62243341 · Oct 19, 2015
Related Publication 20200069195A1 · Mar 5, 2020